Influence of PEGylation on HER2-targeting retro A9 peptide analogue
Authors:
- 5 October 2024
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 138-139, 108963
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Synthesis and 177Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior VariantBioconjugate Chemistry, 2023
- Peptide Ligands Specifically Targeting HER2 Receptor and the Role Played by a Synthetic Model System of the Receptor Extracellular Domain: Hypothesized Future PerspectivesJournal of Medicinal Chemistry, 2020
- Developing PEGylated Reversed D-Peptide as a Novel HER2-Targeted SPECT Imaging Probe for Breast Cancer DetectionBioconjugate Chemistry, 2020
- Strategies for the production of long-acting therapeutics and efficient drug delivery for cancer treatmentBiomedicine & Pharmacotherapy, 2019
- Preliminary PET/CT Imaging with Somatostatin Analogs [68Ga]DOTAGA-TATE and [68Ga]DOTAGA-TOCMolecular Imaging and Biology, 2017
- The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancerCancer and Metastasis Reviews, 2016
- The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel TherapeuticsJournal of Pharmaceutical Sciences, 2008
- PEGylated Interferon-α2b: A Branched 40K Polyethylene Glycol DerivativePharmaceutical Research, 2005
- Effect of pegylation on pharmaceuticalsNature Reviews Drug Discovery, 2003
- Distribution and Tissue Uptake of Poly(ethylene glycol) with Different Molecular Weights after Intravenous Administration to MiceJournal of Pharmaceutical Sciences, 1994